5 completed, 1 unknown. 2 Not applicable, 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Interleukin-4: new trials by email Literature Review of Interleukin-4 trials Research Report on Interleukin-4
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interleukin 4 and Interferon Gamma Predictors of Human Papillomavirus Immunotherapy in Warts IL-4 and IFN-γ measurements - Warts Hand, Wart, Genital | Completed | Zagazig University | 80 | 2020-01-03 | 2025-02-19 | |
| Impact of A. Lumbricoides on Pulmonary Aspergillosis Development Interleukin-1B, Interleukin-4, Interleukin-6 - COPD Exacerbation Acute, Ascaris Lumbricoides Infection | Not applicable | Unknown | Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan | 200 | 2015-05-01 | 2023-08-01 |
| Mother-caregivers of Children With Duchenne Muscular Dystrophy sleep parameters, Hormonal profile, Inflammatory profile - Other Diseases or Conditions | Not applicable | Completed | Monica Levy Andersen | 60 | 2013-08-01 | 2016-02-03 |
| Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood WT1 Peptide-Pulsed Dendritic Cells, Donor Lymphocytes, IL-4 - Leukemia, Acute Myelogenous (AML), Leukemia, Acute Lymphocytic (ALL) | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 10 | 2008-02-22 | 2017-04-12 |
| A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas EF-1 Peptide, EF-2 Peptide, PXFK Peptide - Ewing's Sarcoma, Rhabdomyosarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 30 | 1996-12-23 | 2019-11-29 |
| A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma Interleukin-4 - Sarcoma, Kaposi, HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 48 | 2021-10-28 |
Acquired Immunodeficiency Syndrome (1) · Ascariasis (1) · Aspergillosis (1) · Condylomata Acuminata (1) · HIV Infections (1) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Leukemia (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Non-Hodgkin (1) · Muscular Dystrophy, Duchenne (1) · Myelodysplastic Syndromes (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Pulmonary Disease, Chronic Obstructive (1)
National Cancer Institute (NCI) (2) · Monica Levy Andersen (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan (1) · Zagazig University (1)
United States (3) · Brazil (1) · Egypt (1) · Uzbekistan (1)
Ayman Marei, MD, PhD (1) · Crystal L Mackall, M.D. (1) · Miles S (1) · Scadden D (1) · Terry J Fry, M.D. (1)